Close Menu

360Dx

AlloSure 3.0 can diagnose the very early stages of T-cell mediated rejection, allowing clinicians to begin anti-rejection therapies and monitor treatment.

Comments from Quest suggest lab buys are becoming more complex while others suggest hospitals will remain reluctant to sell so long as premium pricing persists.

The study, sponsored by the US Centers for Disease Control and Prevention, focused on men who have sex with men and members of their social networks.

Recent studies question the clinical utility of tumor mutational burden as a biomarker for immuno-oncology, and the FDA clearance includes no therapeutic indications.

Recent studies question the clinical utility of tumor mutational burden as a biomarker for immuno-oncology, and the FDA clearance includes no therapeutic indications.